tretinoin

(redirected from Avita)
Also found in: Medical.
Related to Avita: AVISTA, Evita

tret·i·noin

 (trĕt′ĭ-noin′)
n.
An isomer of retinoic acid used topically to treat acne and to mitigate fine facial wrinkling and orally to treat one form of leukemia.

tretinoin

(trəˈtɪnəʊɪn)
n
(Pharmacology) pharmacol a synthetic form of vitamin A used as a drug to treat certain skin conditions and a type of leukemia

tre•tin•o•in

(trəˈtɪn oʊ ɪn)
n.
a drug chemically related to vitamin A, used as a topical ointment to treat skin disorders, esp. acne.
[1960–65; t(ri-) + retino- (< Greek rhētinē resin) + -in1]
Translations

tretinoin

n tretinoína
References in periodicals archive ?
RenovaCare announced it has decisively won against patent challenger, Avita Medical, in a proceeding at the United States Patent Office.
Tissue regenix group, Avita Medical, Zimmer Inc, Aesculap, Inc, Nouvag AG and Surtex Instruments ltd.
Medical technology company Avita Medical (ASX: AVH) has appointed Dale A.
May 10, 2017 -- Avita Medical Limited (OTCQX:AVMXY), a regenerative medicine company focused on the treatment of wounds and skin defects, has filed an inter partes review (IPR) petition against U.
The Avita Nostra jewellery collection from the Limassol Lanitiou Lyceum
The Crimson Wig Sponsors of the Red Wig Walk are Louisiana Healthcare Connections and Avita Pharmacy.
Capstone Technologies Group brings two wholly owned companies into the new company; Avita Beverage Co Inc.
The US Food and Drug Administration has approved Continued Access to ReCell, allowing US burn surgeons participating in Avita Medical's regulatory trial to treat new patients using the Company's cell harvesting device, while the marketing application is under preparation and review, the Company stated.
Avita Medical Ltd has announced it is launching a dedicated clinic for its regenerative skin treatments in Iran.
Under the contract, Avita also has the potential to receive up to $37m when contract options are executed which provide support for further clinical studies potentially required by the FDA as part of post-market surveillance, or as needed to expand the use of ReCell to the paediatric population.
Manufactured by Avita Medical, this investigational autologous cell harvesting device is used after C[O.
S AVITA added,"The better results we are achieving now are a direct result of the improved fitness level of the team.